Category: Events
October was a busy month for biodrook™: our solutions are increasingly used in clinical practice, and our team took an active part in key professional events across the industry.
Clinical practice Six successful surgeries were performed in October using biodrook™ solutions. Each case confirms the reliability of our implants and the growing trust of surgeons in Ukrainian-made products.

General sponsorship in Poltava biodrook™ served as general sponsor of a scientific and practical conference in Poltava, supporting continuing education for medical professionals in the region.

Trauma Congress Ukraine 2026 The biodrook™ team joined discussions on reconstructive surgery and complex clinical cases, exchanging experience with leading specialists in the field.

LOTOS 2026 On October 16, we took part in the annual Lviv October Trauma Ortho Symposium in Lviv.

Guests at our facility We welcomed doctors and specialists to our manufacturing facility, showing our production processes and quality standards and discussing opportunities for further collaboration.

We continue working to ensure that doctors have reliable tools and patients can return to movement and a full life💙
biodrook™ at LOTOS 2026: Advancing Dialogue in Orthopedics and Traumatology
On October 16, 2026, the biodrook™ team attended LOTOS 2026 (Lviv October Trauma Ortho Symposium) in Lviv, Ukraine. The symposium focused on current challenges in orthopedics and traumatology, modern surgical approaches, and the treatment of complex clinical cases. The event provided an opportunity for medical professionals to exchange knowledge and discuss approaches to traumatic injuries, bone defects, and reconstructive surgery.Key Topics in Medical Technology Development
For biodrook™, topics related to personalized treatment, bone preservation, and the application of modern technologies in reconstructive surgery were particularly relevant. Several areas closely align with our work:- Patient-specific implants. Considering individual anatomy and the characteristics of bone defects when planning reconstruction.
- 3D printing in orthopedics. Exploring the potential of additive manufacturing to produce implants tailored to specific clinical needs.
- Biomaterials for bone reconstruction. Understanding the role of material composition and properties in the development of implant solutions.
biodrook™ and ResorBone™
biodrook™ develops ResorBone™ — patient-specific bioresorbable implants made from a composite of polylactic acid (PLA) and hydroxyapatite. This approach combines personalized implant design with biomaterial development focused on supporting bone healing. Participation in LOTOS 2026 gave our team an opportunity to engage with the medical community, exchange perspectives, and gain further insight into the clinical challenges faced by specialists in orthopedics and traumatology. We thank the LOTOS 2026 organizers, speakers, and participants for the professional exchange and discussions on the future of medical technology.biodrook™ Supports the All-Ukrainian Scientific and Practical Conference with International Participation in Poltava
On October 8–9, 2026, Poltava State Medical University hosted an All-Ukrainian Scientific and Practical Conference with International Participation, bringing together medical professionals from Ukraine, the United States, Germany, Azerbaijan, Uzbekistan, and Georgia. One of the key topics was the application of patient-specific implants and 3D printing technologies in reconstructive surgery.Patient-Specific Implants: Technology and Clinical Experience
The scientific program featured presentations exploring modern approaches to bone defect reconstruction using customized implants. Denys Chernohorskyi presented the potential of 3D-printed hydroxyapatite and polylactide implants in facial reconstructive surgery, highlighting initial clinical outcomes. Yevhenii Shumynskyi shared his clinical experience with ResorBone™ patient-specific implants, developed and manufactured by biodrook™. These presentations contributed to a professional discussion on the role of personalized medical devices in reconstructive surgery and their integration into clinical practice.biodrook™ as General Sponsor
biodrook™ proudly served as the general sponsor of the conference, supporting the exchange of clinical experience, professional collaboration, and the advancement of innovative medical approaches. For biodrook™, participating in events like this is an important part of engaging with the medical community. Close collaboration with practicing surgeons helps us continuously improve patient-specific solutions based on real clinical needs. We sincerely thank Denys Chernohorskyi and Yevhenii Shumynskyi for their insightful presentations and contributions to the clinical discussion. We also extend our appreciation to Poltava State Medical University, the organizers, and all participants for creating a platform for meaningful professional exchange. biodrook™ — advancing personalized medical solutions together with healthcare professionals.On September 15, 2026, the biodrook team attended Digital Medicine Forum 2026 — a business forum on the digital transformation of medicine. Over 250 attendees and 30+ speakers gathered, including clinic leaders, MedTech and IT companies, eHealth representatives, and the public sector.
The conversation centered on AI in clinical practice, telemedicine, digital radiology, and medical data protection. This is core territory for biodrook: our process starts with a patient’s CT or MRI scan and ends with a sterile, patient-specific implant,so the more digitized a clinic is, the faster a surgeon gets an implant matched to the exact anatomy.
Thank you to the organizers and everyone for the meaningful conversations.
August was a month of national dialogue, growing clinical education, and confirmed quality standards for biodrook. Our team took part in key national events, continued expanding our clinical education library, joined a specialised medical conference, and confirmed compliance with an international quality standard.
We remain committed to advancing regenerative medicine, supporting medical education, and strengthening trust with our partners and physicians.
Forbes University 2026
Our Executive Director, Kateryna Osetrova, took part in Forbes University 2026, meeting new contacts and exploring opportunities for joint R&D projects in medtech.

Expanding Our Clinical Education Library
Our clinical education library continued to expand in August with the filming of new surgical cases for surgeons working with our solutions.

UNIT.City & the NV Leadership Study
UNIT.City hosted the first public presentation of NV’s large-scale study, “Top Managers Who Hold the Country,” followed by an award ceremony recognising the 16 best CEOs in Ukraine.

ERAS: Enhanced Recovery After Surgery Conference
The biodrook team joined a specialised medical conference dedicated to accelerated patient recovery after surgery (ERAS: Enhanced Recovery After Surgery).

ISO 13485 Compliance Confirmed
biodrook successfully passed its surveillance audit, confirming compliance with ISO 13485, which validates the quality, traceability, and reliability of our processes.

Ukraine’s State Flag Day & Independence Day
On 23 and 24 August, Ukraine marked State Flag Day and the 35th anniversary of its Independence 💙💛

Summary
August reaffirmed that the growth of regenerative medicine goes hand in hand with leadership dialogue, professional recognition, and continuous quality improvement.
The biodrook team remains focused on advancing innovative biomaterials, supporting medical education, and strengthening partner trust — so Ukrainian doctors have access to world-class solutions.
Closing block
CONTACT US: info@biodrook.com
Start building the future of accessible biotechnology with biodrook today!
Volyn-Rivne Meetings
On August 28, 2026, the biodrook team took part in a specialized medical conference dedicated to fast-track patient recovery after surgery.
The event became a platform for exchanging experience, discussing practical clinical cases, and building new professional connections with experts in the field — this is how modern medicine evolves today.
We thank the organizers and participants for a meaningful professional dialogue.
Innovation in medtech is not only about technology. It’s also about building a business that can grow around it.
Today, the biodrook team joined the Embedded Finance for Business conference by eDilo at UNIT.City in Kyiv.
The event brought together businesses, financial institutions and international partners to discuss a topic that is highly relevant for growing Ukrainian companies: how new financial models, partnerships and access to capital can support sustainable growth.
For biodrook, these conversations matter.
As we develop and manufacture patient-specific medical implants in Ukraine, we are constantly thinking beyond. About how to scale innovation, build strong partnerships and make advanced medical technologies more accessible.
It was great to step outside the medtech bubble for a day, hear how companies from different industries approach growth, and take some new ideas back to our own team.
Thank you to eDilo and the partners for bringing this conversation together.
On July 28, 2026, Med Forum Odesa took place at the Biopharma Plasma donation center in Odesa, Ukraine. The professional event brought together physicians, healthcare professionals, medical interns, and students from a wide range of medical specialties.
Organized by Biopharma Plasma Odesa in partnership with the MEDEA clinic, the forum created a platform for sharing knowledge, practical experience, and modern approaches to patient care.
Participants toured the plasma donation center, connected with colleagues, and joined discussions on important topics in modern healthcare, including:
• the role of blood component donation in saving lives;
• current perspectives on human papillomavirus, prevention, and vaccination;
• the specific aspects of working with isoimmune donors;
• communication with veterans and patients who have experienced blast-related injuries;
• evidence-based treatment decisions and the “just in case” approach;
• vaccination schedules and the importance of immunization;
• new approaches to disease diagnosis;
• the criteria modern patients use when choosing a physician and the factors that build trust.
For the biodrook team, the discussions related to communication with veterans and people affected by blast-related injuries were especially valuable. Supporting these patients requires not only modern medical solutions but also sensitive, consistent, and responsible guidance throughout every stage of treatment and recovery.
Professional events such as Med Forum Odesa help representatives of different healthcare fields better understand one another’s experience, identify new opportunities for collaboration, and contribute to a more patient-centered healthcare system in Ukraine.
We sincerely thank Donation Center Director Kateryna Yefremova, the Biopharma Plasma Odesa team, and the MEDEA clinic for organizing the event, preparing a meaningful program, encouraging open professional dialogue, and creating a space for valuable communication within the medical community.
We believe that the advancement of healthcare begins with knowledge sharing, interdisciplinary collaboration, and a shared commitment to creating better solutions for patients.